Invention Grant
US07691374B2 Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibody
有权
通过抗内皮糖蛋白抗体增强抗肿瘤剂功效的方法
- Patent Title: Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibody
- Patent Title (中): 通过抗内皮糖蛋白抗体增强抗肿瘤剂功效的方法
-
Application No.: US11509873Application Date: 2006-08-25
-
Publication No.: US07691374B2Publication Date: 2010-04-06
- Inventor: Ben K. Seon
- Applicant: Ben K. Seon
- Applicant Address: US NY Buffalo
- Assignee: Health Research, Inc.
- Current Assignee: Health Research, Inc.
- Current Assignee Address: US NY Buffalo
- Agency: Hodgson Russ LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395
Abstract:
The present invention provides a method for enhancing the efficacy of chemotherapeutic agents for therapy of cancer including tumors and other angiogenesis-associated diseases such as rheumatoid arthritis. The method comprises the steps of administering to an individual in need of treatment, a combination of an anti-endoglin antibody and a chemotherapeutic agent. The anti-endoglin antibody and the chemotherapeutic agent may be administered sequentially or concurrently.
Public/Granted literature
- US20070071761A1 Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibody Public/Granted day:2007-03-29
Information query
